Alicia Ortega

University of Arizona — United States

Medicine · Health Sciences

20h-index1.6kcitations64works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

COVID-19 Clinical Research Studies(12), Sepsis Diagnosis and Treatment(9), MicroRNA in disease regulation(6), SARS-CoV-2 and COVID-19 Research(6), Glioma Diagnosis and Treatment(6)

Publications63 total

P-98. Orthopedic Hand Infections: A 10 Year Review of Cases from Southern Arizona
Open Forum Infectious Diseases·2026Open Access
Impact of device-aided therapies on quality of life in patients with Parkinson’s disease. A comparative multicenter observational study
Journal of Neural Transmission·2025
Relationship Between Retinal Vascular Measurements and Anthropometric Indices in Patients Diagnosed with Persistent COVID-19
Journal of Clinical Medicine·2025· 1 citedOpen Access
Plasma miRNome Profiling Reveals Subphenotype-Specific Mortality Prediction Models in Elderly COVID-19 Patients
2025
MicroRNA mapping of bronchial aspirate for molecular phenotyping and prognostication in patients on mechanical ventilation
Molecular Therapy — Nucleic Acids·2025Open Access
Targeting Commensal Bacteria Reprograms the Tumor Microenvironment after Radiation Therapy in a Murine Oral Cavity Tumor Model
International Journal of Radiation Oncology*Biology*Physics·2025
Poor control of viral replication in the lung as major driver of early respiratory failure in ventilated patients with COVID-19
2025Open Access
Machine‐learning analysis identifies “elite” viral controllers with increased survival and homeostatic responses in critical COVID‐19
Clinical and Translational Medicine·2025Open Access
Addressing the unsolved challenges in microRNA-based biomarker development: Suitable endogenous reference microRNAs for SARS-CoV-2 infection severity
International Journal of Biological Macromolecules·2024· 12 citedOpen Access
Synergistic impact of N-antigenemia profiled by a rapid antigen test and low anti-S1 antibodies on the risk of hospitalization in COVID-19
International Journal of Infectious Diseases·2024· 2 citedOpen Access
A blood-based microRNA signature for the early prediction of the respiratory sequelae in critical COVID-19
2023· 1 cited
A plasma microRNA panel strengthens the early prediction of ICU mortality: A multicenter COVID-19 study
2023
Quantification of bacterial DNA in blood using droplet digital PCR: a pilot study
Diagnostic Microbiology and Infectious Disease·2023· 10 cited
A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study
Respiratory Research·2023· 12 citedOpen Access
Biomarkers’ performance in the SEPSIS-3 era
2023Open Access
Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study
Journal of Infection·2022· 6 citedOpen Access
Quantification of bacterial DNA in blood using droplet digital PCR: a pilot study
2022Open Access
N-antigenemia detection by a rapid lateral flow test predicts 90-day mortality in COVID-19: A prospective cohort study
Clinical Microbiology and Infection·2022· 8 citedOpen Access
PRTN3/FCER1A Transcriptomic Ratio Predicts Hospitalization in Primary Care Attenders With Respiratory Infection
Research Square (Research Square)·2022Open Access
Transitioning ifosfamide chemotherapy regimens to the ambulatory setting: reviewing cost savings and safety profile
Supportive Care in Cancer·2021· 5 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Jesús F. Bermejo-Martín(26), Raquel Almansa(19), Miriam Nuño(10), César Aldecoa(9), José Marı́a Eiros Bouza(9), Jessica González(9), Chirag G. Patil(9), Amanda de la Fuente(8), Ana Motos(8), Ricard Ferrer(8), Ferrán Barbé(8), Antoní Torres(8), Rosario Menéndez(8), Anna Moncusí‐Moix(8), Clara Gort‐Paniello(8), Keith L. Black(8), Ana P. Tedim(7), Marta Domínguez‐Gil(7), Laia Fernández‐Barat(7), David de Gonzalo‐Calvo(7)